United Therapeutics (UTHR) Misses Q3 EPS by 16c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $473.11 +0.19%
EPS Growth %: -10.1%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
OCCI, IPX, ALZN, More
EPS Growth %: -10.1%
Financial Fact:
Operating income: 238.6M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $7.16, $0.16 worse than the analyst estimate of $7.32. Revenue for the quarter came in at $799.5 million versus the consensus estimate of $812.87 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein sees downside risk to Apple's December quarter results
- Popular stocks option volume leaders: INTC SPCX ORCL MU MSTR SOFI PLTR GME CRWV NBIS AVGO SNDK
- Schmid: Wonder If US Moving To A Too-big-to Fail AI Ecosystem
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
